Traphagen Investment Advisors LLC Iovance Biotherapeutics, Inc. Transaction History
Traphagen Investment Advisors LLC
- $886 Million
- Q3 2025
A detailed history of Traphagen Investment Advisors LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 38,962 shares of IOVA stock, worth $88,443. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,962
Previous 38,364
1.56%
Holding current value
$88,443
Previous $65,000
29.23%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding IOVA
# of Institutions
289Shares Held
234MCall Options Held
1.12MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$65.8 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$56.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$48.2 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$26.8 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.5 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $358M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...